Takayuki Tsuchiya - Concepedia

Author

Takayuki Tsuchiya

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

T Tsuchiya, T. Tsuchiya, Takayuki TSUCHIYA, Takayuki Tsuchiya

Publications

327

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy Shiga Medical Center for Children

About

Takayuki Tsuchiya is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	212
2	Natural Sciences	2	2	36
3	Health Sciences	1	1	50
4	Public Health	1	1	24
5	Anatomy	1	1	50

Takayuki Tsuchiya

Publications

261

Citations

H-Index

Page 1

	Year	Citations
Ultrasonography in congenital dislocation of the hip. Simultaneous imaging of both hips from in front Shigeo Suzuki, Yoshitaka Kasahara, T. Futami, Journal of Bone and Joint Surgery - British Volume Gross AnatomyImaging AnatomyNew TechniqueMusculoskeletal ImagingMedicine	1991	50
Ultrasonography in transient synovitis and early Perthes' disease T. Futami, Yoshitaka Kasahara, Shigeo Suzuki, Journal of Bone and Joint Surgery - British Volume RheumatologyEarly PerthesClinical FindingAffected HipsTransient Synovitis	1991	48
Magnetic Compression Anastomosis: A Novel Technique for Canalization of Severe Hilar Bile Duct Strictures Takao Itoi, Eigoro Yamanouchi, Toshio Ikeda, Endoscopy Magnetic Compression AnastomosisNovel TechniqueEus-guided Gallbladder DrainageHepatologySutureless Anastomosis	2005	36
Collaborative work on evaluation of ovarian toxicity 3) Effects of 2- or 4- week repeated-dose toxicity and fertility studies with tamoxifen in female rats Shigeharu Tsujioka, Yoshiki Ban, L. David Wise, The Journal of Toxicological Sciences Hormonal ContraceptiveFertilityToxic EffectsReproductive HealthGynecology	2009	24
<i>In Vitro</i> and <i>In Vivo</i> Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase Christopher M. Tan, Charles Gill, Jin Wu, Antimicrobial Agents and Chemotherapy Potent InhibitorAntibiotic AdjuvantEscherichia ColiBacterial Dna GyraseAntimicrobial Chemotherapy	2016	22
Exploration of long-acting implant formulations of hepatitis B drug entecavir Steven J. Henry, Stephanie E. Barrett, Seth Forster, European Journal of Pharmaceutical Sciences Long-acting Implant FormulationsViral HepatitisMedicineAntiviral TherapyHepatitis	2019	18
Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver Hiroyuki Tsuda, Makoto Asamoto, Yoshio Iwahori, Carcinogenesis	1996	15
Ku Antigen Binds to Alu Family DNA Takayuki Tsuchiya, Y. Sa gusa, Takahiro Taira, The Journal of Biochemistry HistocompatibilityPol IiiGeneticsMolecular BiologyAntigen Processing	1998	14
Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in rat for the detection of nervous system injury Kateřina Vlasáková, Takayuki Tsuchiya, Ivy Garfinkel, Frontiers in Neuroscience	2024	13
Skeletal Myopathy in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene Takayuki Tsuchiya, Kiyoshi Kobayashi, Tetsuya Sakairi, Toxicologic Pathology	2002	11

Page 1